Company intelligence / Profile preview

Consilient

Dublin, Ireland

Ownership: Private
Employees: ~85
Development stage: Other

Overview

Consilient Health does not conduct R&D or clinical trials, but commercializes approved medicines for partners. It offers regulatory, market access, and distribution capabilities for third-party products in Europe.

Therapeutic areas: Men's HealthEndocrinologyWomen's Health
Modalities: Small moleculeGeneric drugsBranded genericsValue-added pharmaceuticals
Industry: Consulting

Partnerships

Partnering with international developers/manufacturers to commercialize products in EuropeCommercialization agreement for macimorelin (diagnostic - partner not named)

Beyond the preview

Go deeper on Consilient.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Consilient.

Explore the full profile